Howell, Jessica <br/><br/>
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib.  [electronic resource] 

 -  Oncotarget  May 2017 
 - 36161-36170 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.15322  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers--metabolism<br/>Carcinoma, Hepatocellular--diagnosis<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Inflammation--diagnosis<br/>Liver Neoplasms--diagnosis<br/>Lymphocytes--immunology<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Neutrophils--immunology<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Predictive Value of Tests<br/>Prognosis<br/>Retrospective Studies<br/>Risk<br/>Sorafenib<br/>Survival Analysis